Skip to main content

Table 4 Results of BDCAF in the studied BD patients

From: Expression of miR-146a and miR-155 in Egyptian patients with Behçet’s disease: clinical significance and relationship with disease activity

 

No. of pt. (total no. = 60)

%

Headache

18

30

Mouth ulceration

18

30

Genital ulceration

8

13.3

Erythema

6

10

Skin pustules

15

25

Joint arthalgia

20

33.3

Joint arthritis

19

31.6

Nausea/vomiting/abdominal pain

9

15

Diarrhea & bleeding per rectum

6

10

Eye involvement

39

65

Nervous system involvement

27

45

Major vessel involvement

17

28.3

 

Mean ± standard deviation

Range

Total current activity from 2006

2.35 ± 2.25

0–9